Advertisement
Screener

LEMAITRE VASCULAR, INC. (LMAT) Cash and Cash Equivalents, Period Increase (Decrease)

3.3 / 5 stars · 78/120 Roast Me

LEMAITRE VASCULAR, INC. Cash and Cash Equivalents, Period Increase (Decrease)

LEMAITRE VASCULAR, INC. (LMAT) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$842.00 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-08.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-05-08

  • LEMAITRE VASCULAR, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-03-31 was -$842.00K.
  • LEMAITRE VASCULAR, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-12-31 was $67.00K, a 98.92% decline year-over-year.
  • LEMAITRE VASCULAR, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was -$1.54M, a 431.55% decline year-over-year.
  • LEMAITRE VASCULAR, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was -$1.50M.
  • LEMAITRE VASCULAR, INC. cash and cash equivalents, period increase (decrease) for fiscal 2019 was -$14.53M, a 301.22% decline from fiscal 2018.
  • LEMAITRE VASCULAR, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $7.22M.
  • LEMAITRE VASCULAR, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$5.19M.
  • LEMAITRE VASCULAR, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was -$3.16M, a 136.11% decline from fiscal 2015.
Period endCash and Cash Equivalents, Period Increase (Decrease) 3 monthCash and Cash Equivalents, Period Increase (Decrease) 6 monthCash and Cash Equivalents, Period Increase (Decrease) 9 monthCash and Cash Equivalents, Period Increase (Decrease) 12 month
2020-03-31-$842.00K
10-Q · filed 2020-05-08
-$775.00K
derived: sum of 2 quarters · filed 2020-05-08
-$2.32M
derived: sum of 3 quarters · filed 2020-05-08
-$3.82M
derived: sum of 4 quarters · filed 2020-05-08
2019-12-31$67.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
-$1.48M
derived: sum of 2 quarters · filed 2020-03-12
-$2.98M
derived: sum of 3 quarters · filed 2020-03-12
-$14.53M
10-K · filed 2020-03-12
2019-09-30-$1.54M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$3.05M
derived: sum of 2 quarters · filed 2019-11-08
-$14.60M
10-Q · filed 2019-11-08
-$8.38M
derived: sum of 4 quarters · filed 2020-05-08
2019-06-30-$1.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
-$13.05M
10-Q · filed 2019-08-06
-$6.84M
derived: sum of 3 quarters · filed 2020-05-08
-$6.37M
derived: sum of 4 quarters · filed 2020-05-08
2019-03-31-$11.55M
10-Q · filed 2020-05-08
-$5.34M
derived: sum of 2 quarters · filed 2020-05-08
-$4.87M
derived: sum of 3 quarters · filed 2020-05-08
-$8.02M
derived: sum of 4 quarters · filed 2020-05-08
2018-12-31$6.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
$6.68M
derived: sum of 2 quarters · filed 2020-03-12
$3.54M
derived: sum of 3 quarters · filed 2020-03-12
$7.22M
10-K · filed 2020-03-12
2018-09-30$466.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$2.68M
derived: sum of 2 quarters · filed 2019-11-08
$1.01M
10-Q · filed 2019-11-08
-$17.41M
derived: sum of 4 quarters · filed 2020-03-12
2018-06-30-$3.14M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
$542.00K
10-Q · filed 2019-08-06
-$17.88M
derived: sum of 3 quarters · filed 2020-03-12
-$10.48M
derived: sum of 4 quarters · filed 2020-03-12
2018-03-31$3.69M
10-Q · filed 2019-05-06
-$14.73M
derived: sum of 2 quarters · filed 2020-03-12
-$7.34M
derived: sum of 3 quarters · filed 2020-03-12
-$3.03M
derived: sum of 4 quarters · filed 2020-03-12
2017-12-31-$18.42M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
-$11.02M
derived: sum of 2 quarters · filed 2020-03-12
-$6.71M
derived: sum of 3 quarters · filed 2020-03-12
-$5.19M
10-K · filed 2020-03-12
2017-09-30$7.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
$11.70M
derived: sum of 2 quarters · filed 2018-11-02
$13.23M
10-Q · filed 2018-11-02
$2.86M
derived: sum of 4 quarters · filed 2019-03-11
2017-06-30$4.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06
$5.83M
10-Q · filed 2018-08-06
-$4.53M
derived: sum of 3 quarters · filed 2019-03-11
$805.00K
derived: sum of 4 quarters · filed 2019-03-11
2017-03-31$1.52M
10-Q · filed 2018-05-04
-$8.84M
derived: sum of 2 quarters · filed 2019-03-11
-$3.50M
derived: sum of 3 quarters · filed 2019-03-11
-$131.00K
derived: sum of 4 quarters · filed 2019-03-11
2016-12-31-$10.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11
-$5.03M
derived: sum of 2 quarters · filed 2019-03-11
-$1.65M
derived: sum of 3 quarters · filed 2019-03-11
-$3.16M
10-K · filed 2019-03-11
2016-09-30$5.33M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
$8.71M
derived: sum of 2 quarters · filed 2017-11-03
$7.20M
10-Q · filed 2017-11-03
$11.02M
derived: sum of 4 quarters · filed 2018-03-09
2016-06-30$3.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
$1.86M
10-Q · filed 2017-08-03
$5.69M
derived: sum of 3 quarters · filed 2018-03-09
$9.88M
derived: sum of 4 quarters · filed 2018-03-09
2016-03-31-$1.51M
10-Q · filed 2017-05-04
$2.31M
derived: sum of 2 quarters · filed 2018-03-09
$6.51M
derived: sum of 3 quarters · filed 2018-03-09
$8.92M
derived: sum of 4 quarters · filed 2018-03-09
2015-12-31$3.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09
$8.02M
derived: sum of 2 quarters · filed 2018-03-09
$10.43M
derived: sum of 3 quarters · filed 2018-03-09
$8.76M
10-K · filed 2018-03-09
2015-09-30$4.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04
$6.60M
derived: sum of 2 quarters · filed 2016-11-04
$4.94M
10-Q · filed 2016-11-04
$5.28M
derived: sum of 4 quarters · filed 2017-03-09
2015-06-30$2.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
$738.00K
10-Q · filed 2016-08-05
$1.08M
derived: sum of 3 quarters · filed 2017-03-09
-$4.08M
derived: sum of 4 quarters · filed 2017-03-09
2015-03-31-$1.67M
10-Q · filed 2016-05-06
-$1.33M
derived: sum of 2 quarters · filed 2017-03-09
-$6.49M
derived: sum of 3 quarters · filed 2017-03-09
$4.52M
derived: sum of 4 quarters · filed 2017-03-09
2014-12-31$338.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09
-$4.82M
derived: sum of 2 quarters · filed 2017-03-09
$6.19M
derived: sum of 3 quarters · filed 2017-03-09
$3.98M
10-K · filed 2017-03-09
2014-09-30-$5.16M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
$5.85M
derived: sum of 2 quarters · filed 2015-11-06
$3.64M
10-Q · filed 2015-11-06
$4.73M
derived: sum of 4 quarters · filed 2016-03-10
2014-06-30$11.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$8.80M
10-Q · filed 2015-08-06
$9.89M
derived: sum of 3 quarters · filed 2016-03-10
$8.60M
derived: sum of 4 quarters · filed 2016-03-10
2014-03-31-$2.21M
10-Q · filed 2015-05-07
-$1.12M
derived: sum of 2 quarters · filed 2016-03-10
-$2.41M
derived: sum of 3 quarters · filed 2016-03-10
-$2.80M
derived: sum of 4 quarters · filed 2016-03-10
2013-12-31$1.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10
-$199.00K
derived: sum of 2 quarters · filed 2016-03-10
-$591.00K
derived: sum of 3 quarters · filed 2016-03-10
-$1.74M
10-K · filed 2016-03-10
2013-09-30-$1.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
-$1.68M
derived: sum of 2 quarters · filed 2014-11-06
-$2.82M
10-Q · filed 2014-11-06
-$7.01M
derived: sum of 4 quarters · filed 2015-03-18
2013-06-30-$392.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07
-$1.54M
10-Q · filed 2014-08-07
-$5.73M
derived: sum of 3 quarters · filed 2015-03-18
-$5.25M
derived: sum of 4 quarters · filed 2015-03-18
2013-03-31-$1.15M
10-Q · filed 2014-05-08
-$5.34M
derived: sum of 2 quarters · filed 2015-03-18
-$4.86M
derived: sum of 3 quarters · filed 2015-03-18
-$4.32M
derived: sum of 4 quarters · filed 2015-03-18
2012-12-31-$4.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18
-$3.71M
derived: sum of 2 quarters · filed 2015-03-18
-$3.17M
derived: sum of 3 quarters · filed 2015-03-18
-$3.68M
10-K · filed 2015-03-18
2012-09-30$477.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07
$1.02M
derived: sum of 2 quarters · filed 2013-11-07
$507.00K
10-Q · filed 2013-11-07
-$2.45M
derived: sum of 4 quarters · filed 2014-03-21
2012-06-30$540.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
$30.00K
10-Q · filed 2013-08-09
-$2.92M
derived: sum of 3 quarters · filed 2014-03-21
-$1.24M
derived: sum of 4 quarters · filed 2014-03-21
2012-03-31-$510.00K
10-Q · filed 2013-05-08
-$3.46M
derived: sum of 2 quarters · filed 2014-03-21
-$1.78M
derived: sum of 3 quarters · filed 2014-03-21
$519.00K
derived: sum of 4 quarters · filed 2014-03-21
2011-12-31-$2.96M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21
-$1.27M
derived: sum of 2 quarters · filed 2014-03-21
$1.03M
derived: sum of 3 quarters · filed 2014-03-21
-$2.48M
10-K · filed 2014-03-21
2011-09-30$1.68M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$3.98M
derived: sum of 2 quarters · filed 2012-11-09
$473.00K
10-Q · filed 2012-11-09
-$4.37M
derived: sum of 4 quarters · filed 2013-03-27
2011-06-30$2.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10
-$1.21M
10-Q · filed 2012-08-10
-$6.05M
derived: sum of 3 quarters · filed 2013-03-27
-$4.20M
derived: sum of 4 quarters · filed 2013-03-27
2011-03-31-$3.51M
10-Q · filed 2012-05-03
-$8.35M
derived: sum of 2 quarters · filed 2013-03-27
-$6.50M
derived: sum of 3 quarters · filed 2013-03-27
2010-12-31-$4.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-27
-$2.99M
derived: sum of 2 quarters · filed 2013-03-27
-$578.00K
10-K · filed 2013-03-27
2010-09-30$1.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$4.26M
10-Q · filed 2011-11-14
2010-06-30$2.42M
10-Q · filed 2011-08-12
2009-12-31$7.30M
10-K · filed 2012-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
NovoCure Ltd (NVCR)$1.886B-11.87
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
UFP TECHNOLOGIES INC (UFPT)United States$2.308B28.37
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77